Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vinod Rustgi

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Journal of Gastroenterology and Hepatology|November 18, 2004
Combination therapy of thymalfasin (thymosin-alpha 1) and peginterferon alfa-2a in patients with chronic hepatitis C virus infection who are non-responders to standard treatmentVinod Rustgi
Journal of Gastroenterology and Hepatology|January 12, 2005
Combination therapy of thymalfasin (thymosin-alpha 1) and peginterferon alfa-2a in patients with chronic hepatitis C virus infection who are non-responders to standard treatmentVinod Rustgi
Clinics in Liver Disease|April 2, 2018
Prognostic Models in Acute Liver FailureAvantika Mishra, Vinod Rustgi
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 22, 2020
The Microbiome and Hepatocellular CarcinomaPuru Rattan, Carlos D Minacapelli, Vinod Rustgi
Clinics in Liver Disease|March 28, 2024
Pathophysiology of Hepatic Encephalopathy: A Framework for CliniciansAlexander Chen, Christopher Tait, Carlos Minacapelli, et al.
Clinics in Liver Disease|April 2, 2018
Viral Hepatitis and Acute Liver Failure: Still a ProblemDaniel Sedhom, Melroy D'Souza, Elizabeth John, et al.
Annals of Hepatology|May 8, 2020
Blood lead level is associated with advanced liver fibrosis in patients with non-alcoholic fatty liver disease: A nationwide survey (NHANES 2011-2016)Debashis Reja, Michael Makar, Aayush Visaria, et al.
Annals of Hepatology|August 4, 2020
Increased serum selenium levels are associated with reduced risk of advanced liver fibrosis and all-cause mortality in NAFLD patients: National Health and Nutrition Examination Survey (NHANES) IIIMishal Reja, Michael Makar, Aayush Visaria, et al.
Clinics in Liver Disease|October 18, 2025
Therapies and Pipeline for Hepatitis B and Hepatitis DJames Lee, Nishali Shah, Rahul Kukreja, et al.
ACG Case Reports Journal|August 30, 2017
Esophageal Stricture Resulting from Systemic Chemotherapy for Solid MalignancyDaniel Sedhom, Ramy Sedhom, Avantika Mishra, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Journal of Gastroenterology and Hepatology|November 18, 2004
Combination therapy of thymalfasin (thymosin-alpha 1) and peginterferon alfa-2a in patients with chronic hepatitis C virus infection who are non-responders to standard treatmentVinod Rustgi
Journal of Gastroenterology and Hepatology|January 12, 2005
Combination therapy of thymalfasin (thymosin-alpha 1) and peginterferon alfa-2a in patients with chronic hepatitis C virus infection who are non-responders to standard treatmentVinod Rustgi
Clinics in Liver Disease|April 2, 2018
Prognostic Models in Acute Liver FailureAvantika Mishra, Vinod Rustgi
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 22, 2020
The Microbiome and Hepatocellular CarcinomaPuru Rattan, Carlos D Minacapelli, Vinod Rustgi
Clinics in Liver Disease|March 28, 2024
Pathophysiology of Hepatic Encephalopathy: A Framework for CliniciansAlexander Chen, Christopher Tait, Carlos Minacapelli, et al.
Clinics in Liver Disease|April 2, 2018
Viral Hepatitis and Acute Liver Failure: Still a ProblemDaniel Sedhom, Melroy D'Souza, Elizabeth John, et al.
Annals of Hepatology|May 8, 2020
Blood lead level is associated with advanced liver fibrosis in patients with non-alcoholic fatty liver disease: A nationwide survey (NHANES 2011-2016)Debashis Reja, Michael Makar, Aayush Visaria, et al.
Annals of Hepatology|August 4, 2020
Increased serum selenium levels are associated with reduced risk of advanced liver fibrosis and all-cause mortality in NAFLD patients: National Health and Nutrition Examination Survey (NHANES) IIIMishal Reja, Michael Makar, Aayush Visaria, et al.
Clinics in Liver Disease|October 18, 2025
Therapies and Pipeline for Hepatitis B and Hepatitis DJames Lee, Nishali Shah, Rahul Kukreja, et al.
ACG Case Reports Journal|August 30, 2017
Esophageal Stricture Resulting from Systemic Chemotherapy for Solid MalignancyDaniel Sedhom, Ramy Sedhom, Avantika Mishra, et al.
Pageof 5